Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis

  • US 20120142614A1
  • Filed: 12/29/2011
  • Published: 06/07/2012
  • Est. Priority Date: 03/29/2001
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a condition that responds to enhanced cGMP levels in a patient comprising administering to said patient a peptide consisting of SEQ ID NO:

  • 8, wherein said peptide is administered in an amount sufficient to increase water transport in the gastrointestinal tract and induce cGMP production in a gastrointestinal epithelial cell.

View all claims

    Thank you for your feedback